Reven Pharmaceuticals Stock
Bio-Pharmaceutical Company
Sign up today and learn more about Reven Pharmaceuticals Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Reven Pharmaceuticals Stock
Reven Holdings, Inc. is a development-stage bio-pharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and metabolic related conditions.
Funding History
| January 2014 | $1.8M |
|---|---|
| January 2014 | $5.0M |
| February 2015 | $4.4M |
| January 2016 | $10.0M |
| January 2017 | $23.0M |
| January 2019 | $23.0M |
Management
Co-Founder & Chief Executive Officer
Peter Lange
Chief Financial Officer
Jeffrey Halverson
Chief Technology Officer
James Ervin
Chief Operating Officer
Brian Denomme
Chief Medical Officer
Fatih Uckun
Press
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
